W. Stummvoll

652 total citations
22 papers, 459 citations indexed

About

W. Stummvoll is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, W. Stummvoll has authored 22 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 4 papers in Epidemiology. Recurrent topics in W. Stummvoll's work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Medical and Health Sciences Research (4 papers). W. Stummvoll is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Medical and Health Sciences Research (4 papers). W. Stummvoll collaborates with scholars based in Austria, Germany and United Kingdom. W. Stummvoll's co-authors include A. Graf, Gudrun Windbichler, Christian Marth, J. Lahodny, H. Hausmaninger, Elisabeth Müller‐Holzner, Christian Kainz, Ursula Denison, F. Kunz and Raimund Winter and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Atherosclerosis.

In The Last Decade

W. Stummvoll

21 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Stummvoll Austria 9 159 159 158 133 83 22 459
Takuya Ayabe Japan 12 75 0.5× 128 0.8× 112 0.7× 128 1.0× 48 0.6× 35 511
N. Sakuragi Japan 11 47 0.3× 216 1.4× 81 0.5× 183 1.4× 56 0.7× 28 423
Tomoko Hirakawa Japan 12 127 0.8× 158 1.0× 95 0.6× 113 0.8× 115 1.4× 30 467
Tamara Kalir United States 11 57 0.4× 243 1.5× 71 0.4× 271 2.0× 54 0.7× 23 545
Hidehiro Mori Japan 10 211 1.3× 227 1.4× 52 0.3× 193 1.5× 27 0.3× 22 431
Elisabeth Le Nestour France 12 50 0.3× 125 0.8× 53 0.3× 32 0.2× 86 1.0× 18 529
Satoshi Tamauchi Japan 12 93 0.6× 312 2.0× 147 0.9× 220 1.7× 88 1.1× 67 589
Song-Nan Chow Taiwan 7 106 0.7× 57 0.4× 91 0.6× 119 0.9× 57 0.7× 9 308
Gianfranco Zannoni Italy 17 43 0.3× 310 1.9× 169 1.1× 316 2.4× 94 1.1× 42 697
J. Wolf United States 5 70 0.4× 27 0.2× 106 0.7× 83 0.6× 62 0.7× 7 361

Countries citing papers authored by W. Stummvoll

Since Specialization
Citations

This map shows the geographic impact of W. Stummvoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Stummvoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Stummvoll more than expected).

Fields of papers citing papers by W. Stummvoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Stummvoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Stummvoll. The network helps show where W. Stummvoll may publish in the future.

Co-authorship network of co-authors of W. Stummvoll

This figure shows the co-authorship network connecting the top 25 collaborators of W. Stummvoll. A scholar is included among the top collaborators of W. Stummvoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Stummvoll. W. Stummvoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sehouli, Jalid, Alexander Reinthaller, Christian Marth, et al.. (2014). Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study. British Journal of Cancer. 111(8). 1519–1525. 13 indexed citations
2.
Ulrich, U., O. Buchweitz, R. R. Greb, et al.. (2014). National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis. Geburtshilfe und Frauenheilkunde. 74(12). 1104–1118. 47 indexed citations
3.
Ulrich, U., O. Buchweitz, R. R. Greb, et al.. (2013). Interdisciplinary S2k Guidelines for the Diagnosis and Treatment of Endometriosis. Geburtshilfe und Frauenheilkunde. 73(9). 890–898. 20 indexed citations
4.
Petru, Edgar, Alain G. Zeimet, P. Sevelda, et al.. (2012). Austrian Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) guideline for prophylaxis with granulocyte colony-stimulating factors (G-CSF) in gynecologic malignancies, including breast cancer. Wiener klinische Wochenschrift. 124(11-12). 412–418. 1 indexed citations
5.
Doppler, S., et al.. (2012). Cervical biopsies and cytological smears – A comparison of sample materials in HPV diagnostics. Journal of Clinical Virology. 56(1). 69–71. 1 indexed citations
6.
7.
Bösmüller, Hans, Gerald Webersinke, W. Stummvoll, et al.. (2011). Intratumoral lymphocyte density in serous ovarian carcinoma is superior to ERCC1 expression for predicting response to platinum-based therapy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 459(2). 183–191. 26 indexed citations
8.
Petru, Edgar, L. Wildt, W. Stummvoll, et al.. (2009). Konsensus der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG)/Arbeitsgemeinschaft für Gynäkologische Onkologie. Geburtshilfe und Frauenheilkunde. 69(12). 1071–1077. 2 indexed citations
9.
Stummvoll, W., et al.. (2005). Visualization of the endopelvic fascia by transrectal three-dimensional ultrasound. International Urogynecology Journal. 17(2). 165–169. 4 indexed citations
10.
Stummvoll, W., et al.. (2001). Gesellschaftsnachrichten der ÖGGG. Gyn�kologisch-geburtshilfliche Rundschau. 41(4). 264–265. 1 indexed citations
11.
Windbichler, Gudrun, H. Hausmaninger, W. Stummvoll, et al.. (2000). Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial. British Journal of Cancer. 82(6). 1138–1144. 191 indexed citations
12.
Wenzl, René, et al.. (1999). [Effectiveness and tolerance of a gonadotropin releasing hormone (goserelin) in treatment of symptomatic endometriosis].. PubMed. 111(7). 283–8. 4 indexed citations
13.
Lahousen, M., Josef Haas, Hellmuth Pickel, et al.. (1999). Chemotherapy versus Radiotherapy versus Observation for High-Risk Cervical Carcinoma after Radical Hysterectomy: A Randomized, Prospective, Multicenter Trial. Gynecologic Oncology. 73(2). 196–201. 63 indexed citations
14.
Fuith, Lothar C., J. Keckstein, M. Lahousen, et al.. (1998). Leitlinien für die Behandlung von einfachen Ovarialzysten. Gyn�kologisch-geburtshilfliche Rundschau. 38(1). 40–40. 1 indexed citations
15.
Winter, R., Hans Concin, Lothar C. Fuith, et al.. (1997). Leitlinien für die operative Behandlung des Zervixkarzinoms erstellt von der Standardkommission der Osterreichischen Gesellschaft für Gynäkologie und Geburtshilfe. Gyn�kologisch-geburtshilfliche Rundschau. 37(4). 227–229. 2 indexed citations
16.
Stummvoll, W., et al.. (1994). Colordopplersonographische Untersuchungen uteriner Gefässe während der Radiotherapie fortgeschrittener Zervixkarzinome. Gyn�kologisch-geburtshilfliche Rundschau. 34(2). 102–105. 1 indexed citations
17.
Stummvoll, W., et al.. (1993). Combined external and high dose rate intracavitary radiotherapy in the primary treatment of cancer of the uterine cervix. Radiotherapy and Oncology. 27(1). 66–68. 5 indexed citations
18.
Stummvoll, W., et al.. (1989). [Hysterectomy: is the vaginal approach safer than the abdominal?].. PubMed. 29 Suppl 2. 54–7.
19.
Kunz, F. & W. Stummvoll. (1971). Plasma phosphatidylethanolamine — A better indicator in the predictability of atherosclerotic complications?. Atherosclerosis. 13(3). 413–425. 24 indexed citations
20.
Kunz, F. & W. Stummvoll. (1970). The significance of plasma phospholipids inZieve syndrome. Annals of Hematology. 21(4). 210–226. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takuya Ayabe Breakdown of academic impact, for papers by N. Sakuragi Breakdown of academic impact, for papers by Tomoko Hirakawa Breakdown of academic impact, for papers by Tamara Kalir Breakdown of academic impact, for papers by Hidehiro Mori Breakdown of academic impact, for papers by Elisabeth Le Nestour Breakdown of academic impact, for papers by Satoshi Tamauchi Breakdown of academic impact, for papers by Song-Nan Chow Breakdown of academic impact, for papers by Gianfranco Zannoni Breakdown of academic impact, for papers by J. Wolf
Rankless by CCL
2026